Skip to main content
. 2004 Aug;53(8):1145–1150. doi: 10.1136/gut.2003.035212

Figure 1.

Figure 1

 Schematic schedule of the study design with animals allocated into major groups according to the duration of the treatment free interval after the last injection of 1,2-dimethylhydrazine. Mice were then allocated to subgroups with different durations of treatment, with daily injections of 25 μg native glucagon-like peptide 2 (GLP-2), 25 μg Gly2-GLP-2, or phosphate buffered saline (controls).